FM
Therapeutic Areas
CROSSJECT Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ZEPIZURE® (midazolam) | Chemical Poisoning | Registration |
| ZENEO® Epinephrine | Anaphylaxis / Severe Allergy | Late-stage Development |
| ZENEO® Hydrocortisone | Acute Adrenal Crisis (AAC) | Late-stage Development |
| CJT-L29 | Undisclosed (Neurology/Epilepsy) | Discovery/Preclinical |
| CJT-L28 | Undisclosed (Neurology/Psychiatry) | Discovery/Preclinical |
| CJT-L30 | Undisclosed (Endocrinology) | Discovery/Preclinical |
| CJT-L31 | Undisclosed | Discovery/Preclinical |